Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO® (IC51), in 6 months of follow-up
- 7 September 2010
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 28 (39), 6463-6469
- https://doi.org/10.1016/j.vaccine.2010.07.040
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Anaphylaxie nach gleichzeitiger Impfung gegen Masern, Mumps, Röteln und Frühsommer-Meningoenzephalitis aufgrund einer GelatineallergieKlinische Padiatrie, 2005
- Immediate allergic reactions after vaccinations – a post-marketing surveillance reviewEuropean Journal of Pediatrics, 2001
- Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccinesAllergy, 2001
- IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria–tetanus–acellular pertussis (DTaP) vaccinesVaccine, 2000
- Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccinesVaccine, 1998
- Allergic mucocutaneous reactions to Japanese encephalitis vaccineVaccine, 1997
- Systemic Reactions in U.S. Marine Corps Personnel Who Received Japanese Encephalitis VaccineClinical Infectious Diseases, 1997
- Adverse reactions to Japanese encephalitis vaccineThe Lancet, 1991
- Side-effects with Japanese encephalitis vaccineThe Lancet, 1991
- Further experience with Japanese encephalitis vaccineThe Lancet, 1990